申请人:Novartis AG
公开号:US06251911B1
公开(公告)日:2001-06-26
4-Amino-1H-pyrazolo[3,4-d]pyrimidine derivatives of formula I
wherein the substituents are as defined in claim 1, are described.
These compounds inhibit the tyrosine kinase activity of the receptor for epidermal growth factor (EGF) and c-erbB2 kinase and can be used as anti-tumor agents.
4-氨基-1H-吡唑[3,4-d]嘧啶衍生物的公式I如下:
其中,取代基如权利要求1中定义,这些化合物描述了抑制表皮生长因子(EGF)受体和c-erbB2激酶的酪氨酸激酶活性,并可作为抗肿瘤剂使用。